| Bioactivity | Levetimide is a potent and stereoselective inhibitor of [3H](+)pentazocine binding, with a Ki of 2.2 nM[1]. | ||||||||||||
| Invitro | Levetimide potently inhibits [3H]DTG binding although without stereoselectivity (Ki value of 103 nM) [1]. | ||||||||||||
| Name | Levetimide | ||||||||||||
| CAS | 21888-99-3 | ||||||||||||
| Formula | C23H26N2O2 | ||||||||||||
| Molar Mass | 362.46 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. DeHaven-Hudkins DL, et al. Binding of dexetimide and levetimide to [3H](+)pentazocine- and [3H]1,3-di(2-tolyl)guanidine-defined sigma recognition sites. Life Sci. 1991;49(18):PL135-9. |